by Kenjiro | Jun 10, 2023 | news
Rapidemic has been awarded a prestigious Women TechEU grant! As one of the five Dutch companies selected, this recognition is a testament to our team’s relentless pursuit of groundbreaking innovation in the deep-tech sector. 🎉🚀 Through Women TechEU, the...
by Kenjiro | Apr 10, 2023 | news
Rapidemic will be joining the 33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark. We look forward to hearing about the novel developments in the field of medical and clinical microbiology, diagnostics and public...
by Kenjiro | Mar 1, 2023 | news
Rapidemic will join the Hello Tomorrow Deeptech conference and the Investors conference at Station F as a deeptech pioneer. The company will be travelling together with the TechLead Healthtech Delegation. We will be present at the Hello Tomorrow Deeptech drinks, as...
by Kenjiro | Jan 14, 2023 | news
GECCO Biotech & Rapidemic have been awarded a MIT R&D grant for their joint project Rapid-G for a total project worth 556 000€. The teams have bundles forces for the development of novel enzymes for to facilitate faster and more accurate decentralized...
by Kenjiro | Oct 8, 2022 | news
The European Meeting on Molecular Diagnostics (EMMD) is an esteemed event taking place from October 12 to 14, 2022. This gathering brings together leading experts, researchers, and professionals from the field of molecular diagnostics. EMMD serves as a platform for...
by Kenjiro | Sep 1, 2022 | news
Rapidemic is thrilled to have been selected by TechLeap to join the third batch of quickly growing and ambitious healthtech start-ups. We look forward to a meaningful learning experience, to connect with fellow entrepreneurs and to join this national community of tech...
